Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion type Assertion NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_head.
- NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion description "[Tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) is being investigated as a targeted cancer therapeutic and the expression of its pro-apoptotic receptors, DR4 and DR5, increases during colorectal carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_provenance.
- NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion evidence source_evidence_literature NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_provenance.
- NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion SIO_000772 24379239 NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_provenance.
- NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion wasDerivedFrom befree-20150227 NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_provenance.
- NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_assertion wasGeneratedBy ECO_0000203 NP746679.RAa16KVaivLqx51VbcLBZdOlcIFbPgzwGKs7Tjhajqnfw130_provenance.